DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+31.77%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$232M
AUM Growth
+$232M
(+15%)
Cap. Flow
-$33.8M
Cap. Flow
% of AUM
-14.58%
Top 10 Holdings %
Top 10 Hldgs %
46.06%
Holding
89
New
6
Increased
21
Reduced
20
Closed
10
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$5.54M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$3.1M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$2.39M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$2.16M |
| 5 |
Mersana Therapeutics
MRSN
|
$2.12M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$25.4M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$8.93M |
| 3 |
ADXS
Advaxis, Inc.
ADXS
|
$8.65M |
| 4 |
Ascendis Pharma
ASND
|
$3.87M |
| 5 |
argenx
ARGX
|
$2.83M |
Sector Composition
| 1 | Healthcare | 88.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$261M
| $26.7M | 11.51% | 13,680,554 | – | – |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $19.7M | 8.49% | 123,806 +19,500 | +19% | +$3.1M |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $9.58M | 4.13% | 119,718 +27,027 | +29% | +$2.16M |
|
4
AtriCure
ATRC
$1.84B
| $8.54M | 3.68% | 318,729 | – | – |
|
|
ALDR
5
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $7.79M | 3.36% | 571,013 +175,000 | +44% | +$2.39M |
|
|
6
Wave Life Sciences
WVE
$1.53B
| $7.4M | 3.19% | 190,554 +142,654 | +298% | +$5.54M |
|
|
AERI
7
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $7.21M | 3.11% | 151,770 +10,000 | +7% | +$475K |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $7.14M | 3.08% | 129,764 -14,000 | -10% | -$770K |
|
9
iShares Biotechnology ETF
IBB
$5.6B
| $6.87M | 2.96% | 61,400 -3,500 | -5% | -$391K |
|
10
Akebia Therapeutics
AKBA
$833M
| $5.86M | 2.53% | 715,538 | – | – |
|
11
Galapagos
GLPG
$2.07B
| $5.84M | 2.52% | 49,609 +8,000 | +19% | +$942K |
|
|
12
Ascendis Pharma
ASND
$11.8B
| $5.22M | 2.25% | 44,380 -32,862 | -43% | -$3.87M |
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $4.85M | 2.09% | 55,008 | – | – |
|
14
VYNE Therapeutics
VYNE
$8.16M
| $4.71M | 2.03% | 600,030 +59,393 | +11% | +$466K |
|
|
15
argenx
ARGX
$43.6B
| $4.45M | 1.92% | 35,650 -22,650 | -39% | -$2.83M |
|
|
BLUE
16
DELISTED
bluebird bio
BLUE
| $4.25M | 1.83% | 27,000 | – | – |
|
|
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.21M | 1.82% | 93,942 | – | – |
|
|
BHVN
18
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.12M | 1.78% | 80,000 | – | – |
|
19
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.06M | 1.75% | 498,415 +34,000 | +7% | +$277K |
|
20
DexCom
DXCM
$29.5B
| $3.85M | 1.66% | 32,338 -1,662 | -5% | -$198K |
|
|
CBAY
21
DELISTED
Cymabay Therapeutics
CBAY
| $3.7M | 1.6% | 278,811 -53,700 | -16% | -$713K |
|
22
ProQR Therapeutics
PRQR
$237M
| $3.63M | 1.56% | 261,521 -10,953 | -4% | -$152K |
|
23
Xenon Pharmaceuticals
XENE
$2.98B
| $3.36M | 1.45% | 330,667 +92,984 | +39% | +$945K |
|
24
Cytokinetics
CYTK
$4.23B
| $3.24M | 1.4% | 400,294 +214,468 | +115% | +$1.73M |
|
|
LMNX
25
DELISTED
Luminex Corp
LMNX
| $3.18M | 1.37% | 138,391 | – | – |
|